Warfarin or other oral anticoagulants should be administered at least one hour before or four to six hours after cholestyramine. The INR or PT should be closely monitored. Patients should be advised to promptly report any signs of bleeding (e.g., pain, swelling, headache, dizziness, weakness, vaginal bleeding, nosebleeds, bleeding of gums from brushing, unusual bleeding or bruising, red or brown urine, or red or black stools) or clots (e.g. chest pain, shortness of breath, sudden loss of vision, or pain, redness or swelling in an extremity).
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 7 Oct 2009 • 1 answer
After taking prevalite for several years I read on the label that I should take other medications an
Posted 19 Jul 2011 • 1 answer
Posted 7 Jun 2013 • 1 answer
Posted 11 Jan 2017 • 0 answers
Posted 4 Jul 2017 • 0 answers